Proteomics of breast cancer

Emanuel F. Petricoin*, Julia Wulfkuhle, Virginia Espina, Lance A. Liotta

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Translational medicine is advancing rapidly. Cancer appears to be at the vortex of much of this activity, with proteomic technology emerging and commingling with ongoing genomic analysis for direct bedside applications. Often proteomics is viewed as a list-generating exercise. This view would be wrong, however. The ultimate goal of proteomics, and particularly clinical proteomics, is really threefold: 1. To characterize the information flow through molecular networks in diseased cells and in tissue and how that information content changes during therapeutic intervention.

Original languageEnglish
Title of host publicationTextbook of Breast Cancer
Subtitle of host publicationA Clinical Guide to Therapy
PublisherCRC Press
Pages101-113
Number of pages13
ISBN (Electronic)9781482202878
ISBN (Print)9781841844183
StatePublished - 17 Jan 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Proteomics of breast cancer'. Together they form a unique fingerprint.

Cite this